ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Webcast Today - New Data from bioMUSE Natural History Study, page-59

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 797 Posts.
    lightbulb Created with Sketch. 229
    Hi Outlander2 and Scott,

    FYI there is an interesting press article in today's (Saturday) West Australian newspaper about PAA ........ mainly focused on the reappointment of the CEO "following a $1billion sales target bungle-- and handed him a massive pay rise".

    It's amazing to me, but probably not to you both with your obvious medical knowledge, how a company with an approved product for worm infestation in sheep, can repurpose the product to treat neurodegenerative diseases, MND etc. The mind boggles (mine anyway!)

    But it appears as if it is going full steam ahead with a Phase 2 study due to commence this quarter of 2024.

    cheers...........Learner


 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $34 10K

Buyers (Bids)

No. Vol. Price($)
28 17196248 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 130790145 27
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.